Notre groupe organise plus de 3 000 séries de conférences Événements chaque année aux États-Unis, en Europe et en Europe. Asie avec le soutien de 1 000 autres Sociétés scientifiques et publie plus de 700 Open Access Revues qui contiennent plus de 50 000 personnalités éminentes, des scientifiques réputés en tant que membres du comité de rédaction.
Les revues en libre accès gagnent plus de lecteurs et de citations
700 revues et 15 000 000 de lecteurs Chaque revue attire plus de 25 000 lecteurs
Dr. Alias Adoresm
Asthma may be a common illness in pediatrics and grown-ups with a critical dismalness, mortality, and budgetary burden around the world. Asthma is presently recognized as a heterogeneous illness and developing clinical and research facility inquire about has elucidated understanding of asthma’s fundamental immunology. The longer term of asthma is classifying asthma by endotype through interfacing perceivable characteristics with immunological instruments. This comprehensive audit of the immunology of asthma points of interest the as of now known pathophysiology and clinical hone biomarkers in expansion to bleeding edge biologic and focused on treatments for all of the asthma endotypes. By understanding the immunology of asthma, specialists will be able to analyze patients by asthma endotype and give personalized, biomarker-driven medications to successfully control patients’ asthma.